The global Biopharmaceuticals market was valued at $82330 million in 2020 and is projected to reach $113300 million by 2027, registering a CAGR of 4.7% from 2021 to 2027. A biopharmaceutical, also known as a biologic (al) medical product, biological, or biologic, is any pharmaceutical drug product manufactured in, extracted from, or semi synthesized from biological sources. Different from totally synthesized pharmaceuticals, they include vaccines, blood, blood components, allergenic, somatic cells, gene therapies, tissues, recombinant therapeutic protein, and living cells used in cell therapy. Biologics can be composed of sugars, proteins, or nucleic acids or complex combinations of these substances, or maybe living cells or tissues. They (or their precursors or components) are isolated from living sources—human, animal, plant, fungal, or microbial.

Biopharmaceuticals Market Analysis

It is costly to discover and develop new drugs/medicines due to expensive research processes, Costs associated with clinical trials, resource-intensive approval procedures and costs associated With manufacturing (if the trials are successful).

Biopharmaceuticals Market Trends

The global population of the elderly is rapidly growing. This rise is propelling the global biopharmaceuticals market size forward, as the elderly population is more susceptible to illness due to poor immunity and long recovery times.

Furthermore, the rising prevalence of chronic diseases as a result of unhealthy lifestyles, poor diets, excessive alcohol intake, and a lack of physical activity are all contributing factors to the rise of biopharmaceutical market size. Many pharmaceutical firms are concentrating their efforts on creating more successful treatments for life-threatening illnesses and encouraging people to live healthy lives with fewer disabilities.

The possibility of side effects associated with certain small-molecule therapeutics and invasive surgical procedures is driving up market demand for biopharmaceuticals. Biopharmaceuticals drugs structurally mimic compounds found within the body and are produced using biotechnologies. These have the potential to cure diseases rather than merely treat symptoms and have fewer side effects because of their specificity. Moreover, because of their efficacy against autoimmune disorders and cancer, as well as their improved mode of action, biopharmaceuticals are expected to replace conventional small molecule drugs in the healthcare industry.

Increasing healthcare investments around the world are precipitating an increase in R&D for biopharmaceuticals. The increased R&D activity is expected to lead to the development of new and more efficient biopharmaceutical products. Thus the increase in healthcare investment is expected to create lucrative growth opportunities for the biopharmaceuticals market.

Biopharmaceuticals Market Segment Review

The Monoclonal Antibodies Segment is expected to be one of the major contributors to the biopharmaceuticals market share. The rapid growth of the segment is due to the active use of monoclonal antibodies and antibody derivatives in therapeutics. Monoclonal antibodies have therapeutic uses in cancer, rheumatoid arthritis, multiple sclerosis, and cardiovascular diseases, among others.

Based on region, North America is expected to be one of the major contributors to the biopharmaceuticals market share. The biopharmaceuticals market in North America is being driven by the rising burden of chronic disease and increased investment in research and development activities in the United States. The United States is known as the world's life sciences innovation capital, and it is active in global capital investments in biopharmaceuticals companies in their early stages.

Biopharmaceuticals market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Biopharmaceuticals market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Biopharmaceuticals Market by Type

Monoclonal Antibodies
Interferon
Colony-Stimulating Factor
Erythropoietin
Insulin
Vaccines
Growth Hormones
Others

Biopharmaceuticals Market by Application

Tumor
Diabetes
Cardiovascular
Hemophilia
Others

Biopharmaceuticals Market by Region

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

Major Players in the Biopharmaceuticals Market

Roche
Amgen
AbbVie
Sanofi-Aventis
Johnson & Johnson
Pfizer
Novo Nordisk
Eli Lilly
Novartis
Merck

Biopharmaceuticals Market Report Coverage

Report Metric	Details
Base Year:	2020
Market Size in 2020:	USD 82330 Million
Forecast Period:	2021 to 2027
Forecast Period 2021 to 2027 CAGR:	4.7%
Largest Market	North America
2027 Value Projection:	USD 113300 Million
No. of Pages:	109
Tables & Figures	132
Segments covered:	Type, Application, Region

Frequently Asked Questions About This Report

1. What will be the global Biopharmaceuticals Market size from 2020 to 2027?

Ans. The global Biopharmaceuticals market was valued at $82330 million in 2020 and is projected to reach $113300 million by 2027

2. What is the growth rate of the global Biopharmaceuticals Market during the forecast period?

Ans. The global Biopharmaceuticals market is estimated to grow with a CAGR of 4.7% during the forecast period

3. What are the upcoming trends or opportunities in the Biopharmaceuticals market?

Ans. Growing geriatric population, rising chronic diseases, and increasing acceptance in the healthcare industry.

4. Who are the top companies hold the market share in the Biopharmaceuticals market?

Ans. Major companies across the market are Roche, Amgen Inc, AbbVie, Sanofi Aventis, Johnson & Johnson, Pfizer Inc, Novo Nordisk, Eli Lilly, Novartis, Merck, World Health Organization, Others are positively contributing to the global market forecast.

5. Does the report provide COVID-19 impact analysis?

Ans. Yes, the report includes a COVID-19 impact analysis. Also, it is further extended into every individual segment of the report.

FEATURED COMPANIES

World Health Organization

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Biopharmaceuticals Market Size Growth Rate by Type: 2016 VS 2021 VS 2027

1.2.2 Monoclonal Antibodies

1.2.3 Interferon

1.2.4 Colony-Stimulating Factor

1.2.5 Erythropoietin

1.2.6 Insulin

1.2.7 Vaccines

1.2.8 Growth Hormones

1.2.9 Others

1.3 Market by Application

1.3.1 Global Biopharmaceuticals Market Share by Application: 2016 VS 2021 VS 2027

1.3.2 Tumor

1.3.3 Diabetes

1.3.4 Cardiovascular

1.3.5 Hemophilia

1.3.6 Others

1.4 Study Objectives

1.5 Years Considered

2 Global Growth Trends

2.1 Global Biopharmaceuticals Market Perspective (2016-2027)

2.2 Biopharmaceuticals Growth Trends by Regions

2.2.1 Biopharmaceuticals Market Size by Regions: 2016 VS 2021 VS 2027

2.2.2 Biopharmaceuticals Historic Market Share by Regions (2016-2021)

2.2.3 Biopharmaceuticals Forecasted Market Size by Regions (2022-2027)

2.3 Biopharmaceuticals Industry Dynamic

2.3.1 Biopharmaceuticals Market Trends

2.3.2 Biopharmaceuticals Market Drivers

2.3.3 Biopharmaceuticals Market Challenges

2.3.4 Biopharmaceuticals Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Biopharmaceuticals Players by Revenue

3.1.1 Global Top Biopharmaceuticals Players by Revenue (2016-2021)

3.1.2 Global Biopharmaceuticals Revenue Market Share by Players (2016-2021)

3.2 Global Biopharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

3.3 Players Covered: Ranking by Biopharmaceuticals Revenue

3.4 Global Biopharmaceuticals Market Concentration Ratio

3.4.1 Global Biopharmaceuticals Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Biopharmaceuticals Revenue in 2020

3.5 Biopharmaceuticals Key Players Head office and Area Served

3.6 Key Players Biopharmaceuticals Product Solution and Service

3.7 Date of Enter into Biopharmaceuticals Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Biopharmaceuticals Breakdown Data by Type

4.1 Global Biopharmaceuticals Historic Market Size by Type (2016-2021)

4.2 Global Biopharmaceuticals Forecasted Market Size by Type (2022-2027)

5 Biopharmaceuticals Breakdown Data by Application

5.1 Global Biopharmaceuticals Historic Market Size by Application (2016-2021)

5.2 Global Biopharmaceuticals Forecasted Market Size by Application (2022-2027)

6 North America

6.1 North America Biopharmaceuticals Market Size (2016-2027)

6.2 North America Biopharmaceuticals Market Size by Type

6.2.1 North America Biopharmaceuticals Market Size by Type (2016-2021)

6.2.2 North America Biopharmaceuticals Market Size by Type (2022-2027)

6.2.3 North America Biopharmaceuticals Market Size by Type (2016-2027)

6.3 North America Biopharmaceuticals Market Size by Application

6.3.1 North America Biopharmaceuticals Market Size by Application (2016-2021)

6.3.2 North America Biopharmaceuticals Market Size by Application (2022-2027)

6.3.3 North America Biopharmaceuticals Market Size by Application (2016-2027)

6.4 North America Biopharmaceuticals Market Size by Country

6.4.1 North America Biopharmaceuticals Market Size by Country (2016-2021)

6.4.2 North America Biopharmaceuticals Market Size by Country (2022-2027)

6.4.3 United States

6.4.4 Canada

7 Europe

7.1 Europe Biopharmaceuticals Market Size (2016-2027)

7.2 Europe Biopharmaceuticals Market Size by Type

7.2.1 Europe Biopharmaceuticals Market Size by Type (2016-2021)

7.2.2 Europe Biopharmaceuticals Market Size by Type (2022-2027)

7.2.3 Europe Biopharmaceuticals Market Size by Type (2016-2027)

7.3 Europe Biopharmaceuticals Market Size by Application

7.3.1 Europe Biopharmaceuticals Market Size by Application (2016-2021)

7.3.2 Europe Biopharmaceuticals Market Size by Application (2022-2027)

7.3.3 Europe Biopharmaceuticals Market Size by Application (2016-2027)

7.4 Europe Biopharmaceuticals Market Size by Country

7.4.1 Europe Biopharmaceuticals Market Size by Country (2016-2021)

7.4.2 Europe Biopharmaceuticals Market Size by Country (2022-2027)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic

8 Asia-Pacific

8.1 Asia-Pacific Biopharmaceuticals Market Size (2016-2027)

8.2 Asia-Pacific Biopharmaceuticals Market Size by Type

8.2.1 Asia-Pacific Biopharmaceuticals Market Size by Type (2016-2021)

8.2.2 Asia-Pacific Biopharmaceuticals Market Size by Type (2022-2027)

8.2.3 Asia-Pacific Biopharmaceuticals Market Size by Type (2016-2027)

8.3 Asia-Pacific Biopharmaceuticals Market Size by Application

8.3.1 Asia-Pacific Biopharmaceuticals Market Size by Application (2016-2021)

8.3.2 Asia-Pacific Biopharmaceuticals Market Size by Application (2022-2027)

8.3.3 Asia-Pacific Biopharmaceuticals Market Size by Application (2016-2027)

8.4 Asia-Pacific Biopharmaceuticals Market Size by Region

8.4.1 Asia-Pacific Biopharmaceuticals Market Size by Region (2016-2021)

8.4.2 Asia-Pacific Biopharmaceuticals Market Size by Region (2022-2027)

8.4.3 China

8.4.4 Japan

8.4.5 South Korea

8.4.6 Southeast Asia

8.4.7 India

8.4.8 Australia

9 Latin America

9.1 Latin America Biopharmaceuticals Market Size (2016-2027)

9.2 Latin America Biopharmaceuticals Market Size by Type

9.2.1 Latin America Biopharmaceuticals Market Size by Type (2016-2021)

9.2.2 Latin America Biopharmaceuticals Market Size by Type (2022-2027)

9.2.3 Latin America Biopharmaceuticals Market Size by Type (2016-2027)

9.3 Latin America Biopharmaceuticals Market Size by Application

9.3.1 Latin America Biopharmaceuticals Market Size by Application (2016-2021)

9.3.2 Latin America Biopharmaceuticals Market Size by Application (2022-2027)

9.3.3 Latin America Biopharmaceuticals Market Size by Application (2016-2027)

9.4 Latin America Biopharmaceuticals Market Size by Country

9.4.1 Latin America Biopharmaceuticals Market Size by Country (2016-2021)

9.4.2 Latin America Biopharmaceuticals Market Size by Country (2022-2027)

9.4.3 Mexico

9.4.4 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Biopharmaceuticals Market Size (2016-2027)

10.2 Middle East & Africa Biopharmaceuticals Market Size by Type

10.2.1 Middle East & Africa Biopharmaceuticals Market Size by Type (2016-2021)

10.2.2 Middle East & Africa Biopharmaceuticals Market Size by Type (2022-2027)

10.2.3 Middle East & Africa Biopharmaceuticals Market Size by Type (2016-2027)

10.3 Middle East & Africa Biopharmaceuticals Market Size by Application

10.3.1 Middle East & Africa Biopharmaceuticals Market Size by Application (2016-2021)

10.3.2 Middle East & Africa Biopharmaceuticals Market Size by Application (2022-2027)

10.3.3 Middle East & Africa Biopharmaceuticals Market Size by Application (2016-2027)

10.4 Middle East & Africa Biopharmaceuticals Market Size by Country

10.4.1 Middle East & Africa Biopharmaceuticals Market Size by Country (2016-2021)

10.4.2 Middle East & Africa Biopharmaceuticals Market Size by Country (2022-2027)

10.4.3 Turkey

10.4.4 Saudi Arabia

10.4.5 UAE

11 Key Players Profiles

11.1 Roche

11.1.1 Roche Company Details

11.1.2 Roche Business Overview

11.1.3 Roche Biopharmaceuticals Introduction

11.1.4 Roche Revenue in Biopharmaceuticals Business (2016-2021)

11.1.5 Roche Recent Development

11.2 Amgen

11.2.1 Amgen Company Details

11.2.2 Amgen Business Overview

11.2.3 Amgen Biopharmaceuticals Introduction

11.2.4 Amgen Revenue in Biopharmaceuticals Business (2016-2021)

11.2.5 Amgen Recent Development

11.3 AbbVie

11.3.1 AbbVie Company Details

11.3.2 AbbVie Business Overview

11.3.3 AbbVie Biopharmaceuticals Introduction

11.3.4 AbbVie Revenue in Biopharmaceuticals Business (2016-2021)

11.3.5 AbbVie Recent Development

11.4 Sanofi-Aventis

11.4.1 Sanofi-Aventis Company Details

11.4.2 Sanofi-Aventis Business Overview

11.4.3 Sanofi-Aventis Biopharmaceuticals Introduction

11.4.4 Sanofi-Aventis Revenue in Biopharmaceuticals Business (2016-2021)

11.4.5 Sanofi-Aventis Recent Development

11.5 Johnson & Johnson

11.5.1 Johnson & Johnson Company Details

11.5.2 Johnson & Johnson Business Overview

11.5.3 Johnson & Johnson Biopharmaceuticals Introduction

11.5.4 Johnson & Johnson Revenue in Biopharmaceuticals Business (2016-2021)

11.5.5 Johnson & Johnson Recent Development

11.6 Pfizer

11.6.1 Pfizer Company Details

11.6.2 Pfizer Business Overview

11.6.3 Pfizer Biopharmaceuticals Introduction

11.6.4 Pfizer Revenue in Biopharmaceuticals Business (2016-2021)

11.6.5 Pfizer Recent Development

11.7 Novo Nordisk

11.7.1 Novo Nordisk Company Details

11.7.2 Novo Nordisk Business Overview

11.7.3 Novo Nordisk Biopharmaceuticals Introduction

11.7.4 Novo Nordisk Revenue in Biopharmaceuticals Business (2016-2021)

11.7.5 Novo Nordisk Recent Development

11.8 Eli Lilly

11.8.1 Eli Lilly Company Details

11.8.2 Eli Lilly Business Overview

11.8.3 Eli Lilly Biopharmaceuticals Introduction

11.8.4 Eli Lilly Revenue in Biopharmaceuticals Business (2016-2021)

11.8.5 Eli Lilly Recent Development

11.9 Novartis

11.9.1 Novartis Company Details

11.9.2 Novartis Business Overview

11.9.3 Novartis Biopharmaceuticals Introduction

11.9.4 Novartis Revenue in Biopharmaceuticals Business (2016-2021)

11.9.5 Novartis Recent Development

11.10 Merck

11.10.1 Merck Company Details

11.10.2 Merck Business Overview

11.10.3 Merck Biopharmaceuticals Introduction

11.10.4 Merck Revenue in Biopharmaceuticals Business (2016-2021)

11.10.5 Merck Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

World Health Organization

List of Tables

Table 1. Global Biopharmaceuticals Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027

Table 2. Key Players of Monoclonal Antibodies

Table 3. Key Players of Interferon

Table 4. Key Players of Colony-Stimulating Factor

Table 5. Key Players of Erythropoietin

Table 6. Key Players of Insulin

Table 7. Key Players of Vaccines

Table 8. Key Players of Growth Hormones

Table 9. Key Players of Others

Table 10. Global Biopharmaceuticals Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027

Table 11. Global Biopharmaceuticals Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027

Table 12. Global Biopharmaceuticals Market Size by Regions (2016-2021) & (US$ Million)

Table 13. Global Biopharmaceuticals Market Share by Regions (2016-2021)

Table 14. Global Biopharmaceuticals Forecasted Market Size by Regions (2022-2027) & (US$ Million)

Table 15. Global Biopharmaceuticals Market Share by Regions (2022-2027)

Table 16. Biopharmaceuticals Market Trends

Table 17. Biopharmaceuticals Market Drivers

Table 18. Biopharmaceuticals Market Challenges

Table 19. Biopharmaceuticals Market Restraints

Table 20. Global Biopharmaceuticals Revenue by Players (2016-2021) & (US$ Million)

Table 21. Global Biopharmaceuticals Market Share by Players (2016-2021)

Table 22. Global Top Biopharmaceuticals Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biopharmaceuticals as of 2020)

Table 23. Ranking of Global Top Biopharmaceuticals Companies by Revenue (US$ Million) in 2020

Table 24. Global 5 Largest Players Market Share by Biopharmaceuticals Revenue (CR5 and HHI) & (2016-2021)

Table 25. Key Players Headquarters and Area Served

Table 26. Key Players Biopharmaceuticals Product Solution and Service

Table 27. Date of Enter into Biopharmaceuticals Market

Table 28. Mergers & Acquisitions, Expansion Plans

Table 29. Global Biopharmaceuticals Market Size by Type (2016-2021) (US$ Million)

Table 30. Global Biopharmaceuticals Revenue Market Share by Type (2016-2021)

Table 31. Global Biopharmaceuticals Forecasted Market Size by Type (2022-2027) (US$ Million)

Table 32. Global Biopharmaceuticals Revenue Market Share by Type (2022-2027) & (US$ Million)

Table 33. Global Biopharmaceuticals Market Size Share by Application (2016-2021) & (US$ Million)

Table 34. Global Biopharmaceuticals Revenue Market Share by Application (2016-2021)

Table 35. Global Biopharmaceuticals Forecasted Market Size by Application (2022-2027) (US$ Million)

Table 36. Global Biopharmaceuticals Revenue Market Share by Application (2022-2027) & (US$ Million)

Table 37. North America Biopharmaceuticals Market Size by Type (2016-2021) (US$ Million)

Table 38. North America Biopharmaceuticals Market Size by Type (2022-2027) & (US$ Million)

Table 39. North America Biopharmaceuticals Market Size by Application (2016-2021) (US$ Million)

Table 40. North America Biopharmaceuticals Market Size by Application (2022-2027) & (US$ Million)

Table 41. North America Biopharmaceuticals Market Size by Country (2016-2021) & (US$ Million)

Table 42. North America Biopharmaceuticals Market Size by Country (2022-2027) & (US$ Million)

Table 43. Europe Biopharmaceuticals Market Size by Type (2016-2021) (US$ Million)

Table 44. Europe Biopharmaceuticals Market Size by Type (2022-2027) & (US$ Million)

Table 45. Europe Biopharmaceuticals Market Size by Application (2016-2021) (US$ Million)

Table 46. Europe Biopharmaceuticals Market Size by Application (2022-2027) & (US$ Million)

Table 47. Europe Biopharmaceuticals Market Size by Country (2016-2021) & (US$ Million)

Table 48. Europe Biopharmaceuticals Market Size by Country (2022-2027) & (US$ Million)

Table 49. Asia-Pacific Biopharmaceuticals Market Size by Type (2016-2021) (US$ Million)

Table 50. Asia-Pacific Biopharmaceuticals Market Size by Type (2022-2027) & (US$ Million)

Table 51. Asia-Pacific Biopharmaceuticals Market Size by Application (2016-2021) (US$ Million)

Table 52. Asia-Pacific Biopharmaceuticals Market Size by Application (2022-2027) & (US$ Million)

Table 53. Asia-Pacific Biopharmaceuticals Market Size by Region (2016-2021) & (US$ Million)

Table 54. Asia-Pacific Biopharmaceuticals Market Size by Region (2022-2027) & (US$ Million)

Table 55. Latin America Biopharmaceuticals Market Size by Type (2016-2021) (US$ Million)

Table 56. Latin America Biopharmaceuticals Market Size by Type (2022-2027) & (US$ Million)

Table 57. Latin America Biopharmaceuticals Market Size by Application (2016-2021) (US$ Million)

Table 58. Latin America Biopharmaceuticals Market Size by Application (2022-2027) & (US$ Million)

Table 59. Latin America Biopharmaceuticals Market Size by Country (2016-2021) & (US$ Million)

Table 60. Latin America Biopharmaceuticals Market Size by Country (2022-2027) & (US$ Million)

Table 61. Middle East & Africa Biopharmaceuticals Market Size by Type (2016-2021) (US$ Million)

Table 62. Middle East & Africa Biopharmaceuticals Market Size by Type (2022-2027) & (US$ Million)

Table 63. Middle East & Africa Biopharmaceuticals Market Size by Application (2016-2021) (US$ Million)

Table 64. Middle East & Africa Biopharmaceuticals Market Size by Application (2022-2027) & (US$ Million)

Table 65. Middle East & Africa Biopharmaceuticals Market Size by Country (2016-2021) & (US$ Million)

Table 66. Middle East & Africa Biopharmaceuticals Market Size by Country (2022-2027) & (US$ Million)

Table 67. Roche Company Details

Table 68. Roche Business Overview

Table 69. Roche Biopharmaceuticals Product

Table 70. Roche Revenue in Biopharmaceuticals Business (2016-2021) & (US$ Million)

Table 71. Roche Recent Development

Table 72. Amgen Company Details

Table 73. Amgen Business Overview

Table 74. Amgen Biopharmaceuticals Product

Table 75. Amgen Revenue in Biopharmaceuticals Business (2016-2021) & (US$ Million)

Table 76. Amgen Recent Development

Table 77. AbbVie Company Details

Table 78. AbbVie Business Overview

Table 79. AbbVie Biopharmaceuticals Product

Table 80. AbbVie Revenue in Biopharmaceuticals Business (2016-2021) & (US$ Million)

Table 81. AbbVie Recent Development

Table 82. Sanofi-Aventis Company Details

Table 83. Sanofi-Aventis Business Overview

Table 84. Sanofi-Aventis Biopharmaceuticals Product

Table 85. Sanofi-Aventis Revenue in Biopharmaceuticals Business (2016-2021) & (US$ Million)

Table 86. Sanofi-Aventis Recent Development

Table 87. Johnson & Johnson Company Details

Table 88. Johnson & Johnson Business Overview

Table 89. Johnson & Johnson Biopharmaceuticals Product

Table 90. Johnson & Johnson Revenue in Biopharmaceuticals Business (2016-2021) & (US$ Million)

Table 91. Johnson & Johnson Recent Development

Table 92. Pfizer Company Details

Table 93. Pfizer Business Overview

Table 94. Pfizer Biopharmaceuticals Product

Table 95. Pfizer Revenue in Biopharmaceuticals Business (2016-2021) & (US$ Million)

Table 96. Pfizer Recent Development

Table 97. Novo Nordisk Company Details

Table 98. Novo Nordisk Business Overview

Table 99. Novo Nordisk Biopharmaceuticals Product

Table 100. Novo Nordisk Revenue in Biopharmaceuticals Business (2016-2021) & (US$ Million)

Table 101. Novo Nordisk Recent Development

Table 102. Eli Lilly Company Details

Table 103. Eli Lilly Business Overview

Table 104. Eli Lilly Revenue in Biopharmaceuticals Business (2016-2021) & (US$ Million)

Table 105. Eli Lilly Recent Development

Table 106. Novartis Company Details

Table 107. Novartis Business Overview

Table 108. Novartis Biopharmaceuticals Product

Table 109. Novartis Revenue in Biopharmaceuticals Business (2016-2021) & (US$ Million)

Table 110. Novartis Recent Development

Table 111. Merck Company Details

Table 112. Merck Business Overview

Table 113. Merck Biopharmaceuticals Product

Table 114. Merck Revenue in Biopharmaceuticals Business (2016-2021) & (US$ Million)

Table 115. Merck Recent Development

Table 116. Research Programs/Design for This Report

Table 117. Key Data Information from Secondary Sources

Table 118. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Biopharmaceuticals Market Share by Type: 2020 VS 2027

Figure 2. Monoclonal Antibodies Features

Figure 3. Interferon Features

Figure 4. Colony-Stimulating Factor Features

Figure 5. Erythropoietin Features

Figure 6. Insulin Features

Figure 7. Vaccines Features

Figure 8. Growth Hormones Features

Figure 9. Others Features

Figure 10. Global Biopharmaceuticals Market Share by Application: 2020 VS 2027

Figure 11. Tumor Case Studies

Figure 12. Diabetes Case Studies

Figure 13. Cardiovascular Case Studies

Figure 14. Hemophilia Case Studies

Figure 15. Others Case Studies

Figure 16. Biopharmaceuticals Report Years Considered

Figure 17. Global Biopharmaceuticals Market Size (US$ Million), Year-over-Year: 2016-2027

Figure 18. Global Biopharmaceuticals Market Size (US$ Million), 2016 VS 2021 VS 2027

Figure 19. Global Biopharmaceuticals Market Share by Regions: 2020 VS 2027

Figure 20. Global Biopharmaceuticals Market Share by Regions (2022-2027)

Figure 21. Global Biopharmaceuticals Market Share by Players in 2020

Figure 22. Global Top Biopharmaceuticals Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biopharmaceuticals as of 2020

Figure 23. The Top 10 and 5 Players Market Share by Biopharmaceuticals Revenue in 2020

Figure 24. Global Biopharmaceuticals Revenue Market Share by Type (2016-2021)

Figure 25. Global Biopharmaceuticals Revenue Market Share by Type (2022-2027)

Figure 26. North America Biopharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 27. North America Biopharmaceuticals Market Share by Type (2016-2027)

Figure 28. North America Biopharmaceuticals Market Share by Application (2016-2027)

Figure 29. North America Biopharmaceuticals Market Share by Country (2016-2027)

Figure 30. United States Biopharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 31. Canada Biopharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 32. Europe Biopharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 33. Europe Biopharmaceuticals Market Share by Type (2016-2027)

Figure 34. Europe Biopharmaceuticals Market Share by Application (2016-2027)

Figure 35. Europe Biopharmaceuticals Market Share by Country (2016-2027)

Figure 36. Germany Biopharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 37. France Biopharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 38. U.K. Biopharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 39. Italy Biopharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 40. Russia Biopharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 41. Nordic Biopharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 42. Asia-Pacific Biopharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 43. Asia-Pacific Biopharmaceuticals Market Share by Type (2016-2027)

Figure 44. Asia-Pacific Biopharmaceuticals Market Share by Application (2016-2027)

Figure 45. Asia-Pacific Biopharmaceuticals Market Share by Region (2016-2027)

Figure 46. China Biopharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 47. Japan Biopharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 48. South Korea Biopharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 49. Southeast Asia Biopharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 50. India Biopharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 51. Australia Biopharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 52. Latin America Biopharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 53. Latin America Biopharmaceuticals Market Share by Type (2016-2027)

Figure 54. Latin America Biopharmaceuticals Market Share by Application (2016-2027)

Figure 55. Latin America Biopharmaceuticals Market Share by Country (2016-2027)

Figure 56. Mexico Biopharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 57. Brazil Biopharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 58. Middle East & Africa Biopharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 59. Middle East & Africa Biopharmaceuticals Market Share by Type (2016-2027)

Figure 60. Middle East & Africa Biopharmaceuticals Market Share by Application (2016-2027)

Figure 61. Middle East & Africa Biopharmaceuticals Market Share by Country (2016-2027)

Figure 62. Turkey Biopharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 63. Saudi Arabia Biopharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 64. UAE Biopharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 65. Roche Revenue Growth Rate in Biopharmaceuticals Business (2016-2021)

Figure 66. Amgen Revenue Growth Rate in Biopharmaceuticals Business (2016-2021)

Figure 67. AbbVie Revenue Growth Rate in Biopharmaceuticals Business (2016-2021)

Figure 68. Sanofi-Aventis Revenue Growth Rate in Biopharmaceuticals Business (2016-2021)

Figure 69. Johnson & Johnson Revenue Growth Rate in Biopharmaceuticals Business (2016-2021)

Figure 70. Pfizer Revenue Growth Rate in Biopharmaceuticals Business (2016-2021)

Figure 71. Novo Nordisk Revenue Growth Rate in Biopharmaceuticals Business (2016-2021)

Figure 72. Eli Lilly Revenue Growth Rate in Biopharmaceuticals Business (2016-2021)

Figure 73. Novartis Revenue Growth Rate in Biopharmaceuticals Business (2016-2021)

Figure 74. Merck Revenue Growth Rate in Biopharmaceuticals Business (2016-2021)

Figure 75. Bottom-up and Top-down Approaches for This Report

Figure 76. Data Triangulation

Figure 77. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3900

This license allows only one user(purchaser of the report) to access the PDF.

Multi User

Electronic (PDF)

$5850

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (10% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

Cell Culture Market

Stem Cell Media Market

Serum Free Media Market

Cell Culture Media Market

Life Science Analytics Market

Cell Sorting Market

South Korea Cell Culture Market

Cell Analysis Market

Single Cell Analysis Market

Cell Culture Media for Vaccine Market

Gene Therapy Cell Culture Media Market

Cell Culture Reagent Market

Automated Cell Culture Market

Cell Culture Vessels Market

Cell Culture Media Bags Market

Global Biopharmaceuticals Market Size, Status and Forecast 2021-2027

Published Date: June 2021

Report Code: QYRE-Auto-22J2409

Global Biopharmaceuticals Market Size, Status and Forecast 2021-2027

FEATURED COMPANIES

Biopharmaceuticals Market Analysis - 2027

Biopharmaceuticals Market Trends

Biopharmaceuticals Market Segment Review

Biopharmaceuticals Market by Type

Biopharmaceuticals Market by Application

Biopharmaceuticals Market by Region

Major Players in the Biopharmaceuticals Market

Biopharmaceuticals Market Report Coverage

Frequently Asked Questions About This Report

1. What will be the global Biopharmaceuticals Market size from 2020 to 2027?

2. What is the growth rate of the global Biopharmaceuticals Market during the forecast period?

3. What are the upcoming trends or opportunities in the Biopharmaceuticals market?

4. Who are the top companies hold the market share in the Biopharmaceuticals market?

5. Does the report provide COVID-19 impact analysis?

FEATURED COMPANIES

FEATURED COMPANIES

HAVE A QUERY?

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-26V13549

Mon Nov 11 00:00:00 UTC 2024

120 Pages

Type: Report

Code: QYRE-Auto-17N14065

Mon Nov 11 00:00:00 UTC 2024

120 Pages

Type: Report

Code: QYRE-Auto-6Q14792

Fri Nov 08 00:00:00 UTC 2024

120 Pages

Type: Report

Code: QYRE-Auto-30W13258

Thu Nov 07 00:00:00 UTC 2024

Support Contacts

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

POLICIES

THE COMPANY

CUSTOMER SUPPORT

OUR PRODUCTS

POLICES

Copyright © 2018 Valuates.com. All Rights Reserved.

Sitemap - Privacy Policy - Terms & Conditions